Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study

201685 citationsJournal Article

Authors

Taishi Kuwahara · Yokosuka Kyosai Hospital

Mitsunori Abe · Matsuyama University

Masaru Yamaki · Nayoro City General Hospital

Hiroyuki Fujieda · Matsuyama University

Yumiko Abe · Matsuyama University

Katsushi Hashimoto · Matsuyama University

MISAKO ISHIBA ·

Abstract

Apixaban has similar safety and effectiveness to warfarin for the prevention of cerebral thromboembolism during the periprocedural period of AF ablation.

Topics & Keywords

Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments Acute Ischemic Stroke Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Cardiovascular Electrophysiology

Volume 27, Issue 5, pp. 549-554

DOI: 10.1111/jce.12928

Field-Weighted Citation Impact: 9.90